Pharmacology is a science of medical drug and medication, including a substance's origin, composition, pharmacokinetics, therapeutic use, and toxicology. More specifically, it is the study of the interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function. If substances have medicinal properties, they are considered pharmaceuticals.
Taylor & Francis Group is an international company originating in England that publishes books and academic journals. Its parts include Taylor & Francis, Routledge, F1000 Research and Dovepress. It is a division of Informa plc, a United Kingdom–based publisher and conference company.
Xenobiotica is a peer-reviewed medical journal that publishes comprehensive research papers on all areas of xenobiotics. It is published by Informa plc and covers six main areas:
BioTechniques: the International Journal of Life Science Methods is a peer-reviewed open-access scientific journal published by Future Science Group. It covers laboratory methods and techniques that are of broad interest to professional life scientists, as well as scientists from other disciplines interested in life science applications of their technologies. The journal was established in 1983 by Eaton Associates, which was acquired in 2001 by Informa. The journal was then acquired by Future Science Group in 2018. It is distributed in both print and online form.
Drug Target Insights is a peer-reviewed open access academic journal focusing on drug treatment targets and clinical therapeutics. The journal was founded in 2006 by Monica Milani and is currently edited by Giulio Zuanetti. It was originally published by Libertas Academica, but SAGE Publications became the publisher in September 2016. In 2020, the journal was transferred to AboutScience Srl.
Expert Opinion on Pharmacotherapy is a peer-reviewed medical journal publishing review articles and original papers on new pharmacotherapies. It is published by Informa and the editor-in-chief is Dimitri P. Mikhailidis.
Expert Opinion on Therapeutic Patents is a monthly peer-reviewed medical journal covering pharmaceutical patent information across all therapy areas. Each review includes an "expert opinion" section, in which authors provide their personal view on the current status and future direction of the research discussed. The journal was established as Current Opinion on Therapeutic Patents in 1991, and changed to the current name in 1994. It is published by Informa. The editor-in-chief is Claudiu T. Supuran.
Expert Opinion on Therapeutic Targets is a monthly peer-reviewed medical journal publishing review articles and original papers on recently identified novel molecular drug targets across all therapy areas. It was originally established as Emerging Therapeutic Targets in 1997, changing to its current name in 2001.
The Journal of Receptors and Signal Transduction is a peer-reviewed scientific journal that publishes laboratory and clinical studies, reviews, and brief communications on biological receptors and associated signal transduction pathways for ligands involved in the regulation of central and peripheral tissues and cells. It is published by Informa. The editors in chief are Alex N. Eberle and Terrence Kenakin.
Pharmaceutical Research is an official journal of the American Association of Pharmaceutical Scientists and covers research spanning the entire spectrum of drug discovery, development, evaluation, and regulatory approval. Small drug molecules, biotechnology products including genes, peptides, proteins and vaccines, and genetically engineered cells are an integral part of papers published. Current emphasis of the journal includes the following areas: preformulation; drug delivery and targeting; formulation design, engineering, and processing; pharmacokinetics, pharmacodynamics, and pharmacogenomics; molecular biopharmaceutics and drug disposition; and computational biopharmaceutics, among others.
Expert Opinion on Drug Safety is an international peer-reviewed medical journal publishing review articles on all aspects of pharmacovigilance and original papers on the clinical implications of drug treatment safety issues. It was established in 2002 and is published by Informa. The editor-in-chief is Roger McIntyre.
Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics. The applications of the disciplines of pharmacology, immunology, cell biology, and molecular genetics to intervention in human cancer are also included. One of the main interests of Clinical Cancer Research is on clinical trials that evaluate new treatments together with research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment. Another priority for Clinical Cancer Research is laboratory and animal studies of new drugs as well as molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease. The journal is published by the American Association for Cancer Research.
Leukemia & Lymphoma is a peer-reviewed medical journal published by Informa Healthcare. It covers basic and clinical aspects of hematologic malignancies. The editors-in-chief are Aaron Polliack, Koen Van Besien, and John Seymour.
Somatosensory & Motor Research is a peer-reviewed medical journal that covers all topics relating to the neural bases for somatic sensation, somatic motor function, somatic motor integration, and modeling thereof. The journal has been published quarterly by Informa since 1983. According to the Journal Citation Reports, the journal had a 2016 impact factor of 0.909.
Postgraduate Medicine is a bimonthly peer-reviewed medical journal published by Informa Healthcare. It was established in 1916 with Charles William Mayo as its first editor-in-chief. The current editor-in-chief is Howard A. Miller. The journal is directed towards primary care physicians. It is abstracted and indexed in Index Medicus/MEDLINE/PubMed, the Science Citation Index, and Current Contents/Clinical Medicine.
Current Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang. The journal covers research on contemporary molecular drug targets involved in cancer, including medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry. Current Cancer Drug Targets publishes original research reports, review papers, and rapid communications ("letters").
Expert Review of Hematology is a MEDLINE-indexed, peer-reviewed, international medical journal publishing review articles and original papers on all aspects of hematology. It is part of the Expert Review series, published by Informa.
Expert Review of Pharmacoeconomics & Outcomes Research is a bimonthly peer-reviewed medical journal covering all aspects of pharmacoeconomics. It was established in 2001 and is published by Informa. The editor-in-chief is A. Bottomley.
Expert Review of Gastroenterology & Hepatology is a peer-reviewed medical journal covering all aspects of gastroenterology and hepatology. It was established in 2007 and is published by Informa.
Sufotidine (INN, USAN, codenamed AH25352) is a long-acting competitive H2 receptor antagonist which was under development as an antiulcerant by Glaxo (now GlaxoSmithKline). It was planned to be a follow-up compound to ranitidine (Zantac). When taken in doses of 600 mg twice daily it induced virtually 24-hour gastric anacidity thus closely resembling the antisecretory effect of the proton pump inhibitor omeprazole. Its development was terminated in 1989 from phase III clinical trials based on the appearance of carcinoid tumors in long-term toxicity testing in rodents.
